Internal Medicine, Medical Oncology · Aurora, CO
NPI
1669645867
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
12605 E 16th Ave
Aurora, CO, 80045
Phone (720) 848-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
765 services
Medicare patients, 2024
326
Average age 73
Drug cost, 2024
$1.1M
651 prescriptions
Company payments, 2025
$5,837
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Theresa M Medina was code 99215 (office e&m - established), 279 times for 148 patients. In total Theresa M Medina billed 765 services in 17 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 279 | 148 | $111.13 | $31K |
| 99214 Office E&M - Established | Facility | 274 | 173 | $71.62 | $20K |
| 99214 Office E&M - Established | Office | 65 | 46 | $100.98 | $6,564 |
| 99205 Office E&M - New | Facility | 43 | 43 | $140.11 | $6,025 |
| 99215 Office E&M - Established | Office | 40 | 35 | $141.69 | $5,668 |
| 11102 Skin Biopsy | Facility | 12 | 12 | $27.27 | $327 |
By year: 2022 $73K for 773 services; 2023 $70K for 756 services; 2024 $72K for 765 services.
Medicare prescription drug claims, 2024
In 2024, the drug Theresa M Medina prescribed most often to Medicare patients was Levothyroxine Sodium, with 115 prescriptions and refills. In total Theresa M Medina wrote 651 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 115 | 293 | 30 | $1,308 |
| Prednisone Generic | 58 | 84 | 26 | $465 |
| Eliquis Apixaban | 50 | 61 | Under 11 | $34K |
| Mektovi Binimetinib | 37 | 37 | Under 11 | $463K |
| Braftovi Encorafenib | 35 | 35 | Under 11 | $456K |
| Oxycodone Hcl Generic | 25 | 26 | 15 | $473 |
| Potassium Chloride Generic | 23 | 30 | Under 11 | $294 |
| Pantoprazole Sodium Generic | 15 | 25 | Under 11 | $135 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 20 | 12 | $52.52 |
| Triamcinolone Acetonide Generic | 14 | 19 | 14 | $198 |
| Gabapentin Generic | 14 | 16 | Under 11 | $80.72 |
| Bupropion Xl Bupropion Hcl | 13 | 15 | Under 11 | $170 |
| Ondansetron Hcl Generic | 13 | 14 | 13 | $167 |
| Trazodone Hcl Generic | 12 | 25 | Under 11 | $140 |
| Diazepam Generic | 12 | 12 | Under 11 | $13.08 |
Brand drugs: 202 claims; generic drugs: 449 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Theresa M Medina $5,837 (- in general payments such as food, travel and fees and $5,837 for research) from 9 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $5,837.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 17 | $5,837 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.